<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03622606</url>
  </required_header>
  <id_info>
    <org_study_id>P17/07_R-LAST</org_study_id>
    <nct_id>NCT03622606</nct_id>
  </id_info>
  <brief_title>Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes</brief_title>
  <acronym>R-LAST</acronym>
  <official_title>Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Sud Francilien</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a bi-centric study whose main objective is the validation of a rapid screening test
      for language disorders in the acute phase of right hemisphere stroke.

      Primary objective

      The main objective is the validation of a rapid language disorder screening tool that will be
      used in the acute phase of right hemispheric stroke.

      Secondary objectives

      Secondary objectives are:

        -  Characterize the &quot;atypical crossed aphasia&quot; since the acute phase of stroke with a large
           cohort of patients , which, to our knowledge, has never been done.

        -  Re-evaluate the number of patients with acute language disorder in right hemisphere
           stroke.

        -  Validate the use of R-LAST by different categories of carers
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The R-LAST (Right Language screening test) comprises 8 subtests and a total of 15 items.

      Validation will focus on the internal validity (no ceiling or floor effect, no redundancy,
      internal consistency), the external validity (against a &quot;gold standard&quot; in order to evaluate
      its specificity and its sensitivity) and the interclass agreement of R-LAST. The median time
      to administrate de scale will be calculated.

      The investigators will validate the scale by administering it to 300 consecutive patients
      within 24 hours after admission to our 2 stroke units (Centre Hospitalier de Versailles and
      Centre hospitalier du sud francilien) and to 100 stabilized patients with and without
      atypical crossed aphasia using the MEC-P evaluation as a reference.

      Patients must be 100% right-handed (Edinburgh test), be of French mother tongue, have no
      history of neurological disease, have no sensory disturbances (blindness, deafness) and no
      mirror crossed aphasia detected by the LAST (minimum score of 14/15 with a loss point granted
      for the &quot;automatic speech&quot; subtest, potentially stranded in right strokes)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2018</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Score at R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>Internal validation: no item will present effect floor, ceiling or of redundancy.
Validation inter examiner: the score obtained to R-LAST is independent from the examiner.
External validation: the patients detected by gold standard as presenting a speech difficulty bound to a right hemispherical lesion will also be him by R-LAST (no forgery negatives), and that the patients not presenting speech difficulty during the signing of these standard gold will obtain the maximum score to R-LAST (no forgery positive).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score at LAST A and B</measure>
    <time_frame>Day 1</time_frame>
    <description>Detect the patients presenting a right hemispherical AVC with crossed aphasia &quot;mirror&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of signing R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>To obtain an average time of signing which will have to be shorter than that of the standard gold used during the external validation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Simplicity and convenience of R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>Contains only a sheet printed in black and white and both sides (to avoid the semantic indications bound to the color of an item, and to simplify the reproduction).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual aspect of R-LAST</measure>
    <time_frame>Day 1</time_frame>
    <description>Presentation in &quot;portrait&quot; mode, so that patients presenting a neurovisual disorder of type héminégligence or héminanopsie controlatérale are not penalized</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Acute and subacute phase of right stroke</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention will be the passation of Right Language Screening Test (R-LAST).
Patients in acute phase of right hemispheric stroke will be used for the internal validation and the integrated reliability of the Right Language screening test.
Patients in subacute phase of right hemispheric stroke will be used for the external validation of the Right Language screening test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Right Language screening test (R-LAST)</intervention_name>
    <description>Validation of the Right Language screening test in acute and subacute phase of right stroke</description>
    <arm_group_label>Acute and subacute phase of right stroke</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients must be the age of majority

          -  Patients with right hemispheric stroke in the acute phase (internal validation +
             inter-examiner validation) or stabilization phase (external validation) confirmed by
             MRI or CT when MRI contraindicated

          -  Patient with no &quot;mirror&quot; crossed aphasia detected by the LAST procedure (A or B):
             LAST&gt; 14

          -  Patients who read the newsletter

          -  Affiliation to a social security scheme

        Criteria Exclusion:

          -  Minor patients

          -  No French speakers

          -  Patients with a history of stroke

          -  Patients with dementia

          -  Patients with sensory impairment: deafness, blindness

          -  Patient not 100% right handed in the Edinburgh questionnaire

          -  Inability to answer the Edinburgh Laterality Questionnaire and absence of any person
             to fill in the questionnaire.

          -  Patient with a left-handed person in its family

          -  Illiterate patients

          -  Patient presenting a &quot;mirror&quot; crossed aphasia detected by LAST A or B (score
             tolerated: 14/15 with error accepted to the automatic speech)

          -  Inability to receive the information letter about the protocol and to read the
             newsletter

          -  Refusal of the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier SMADJA, Neurologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sud Francilien Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Constance FLAMAND-ROZE, NeuroScientist</last_name>
    <phone>0611561520</phone>
    <email>constance.flamand.roze@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>virginie chatagner, ProjectManager</last_name>
    <phone>01 39 23 97 76</phone>
    <email>vchatagner@ch-versailles.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CH Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Constance FLAMAND-ROZE</last_name>
      <email>constance.flamand.roze@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Didier SMADJA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wendy REGNIER</last_name>
      <email>wregnier@ch-versailles.fr</email>
    </contact>
    <investigator>
      <last_name>Fernando PICO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>August 27, 2019</last_update_submitted>
  <last_update_submitted_qc>August 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Dr Constance FLAMAND-ROZE</investigator_full_name>
    <investigator_title>Neurosciences doctor</investigator_title>
  </responsible_party>
  <keyword>Right hemispheric Stroke</keyword>
  <keyword>Crossed aphasia</keyword>
  <keyword>Acute phase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

